Ceftriaxone for methicillin-susceptible <i>Staphylococcus aureus</i> bloodstream infections is associated with increased short-term mortality: a systematic review and meta-analysis.

Ann Med · 2026 · PMC13162535 · PMID 42112603

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The pooled OR was 0.49 (95% CI: 0.23–1.05), suggesting lower clinical success in the ceftriaxone group compared to SoC, although the association did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Ceftriaxone for methicillin-susceptible &lt;i&gt;Staphylococcus aureus&lt;/i&gt; bloodstream infections is associated with increased short-term mortality: a systematic review and meta-analysis.

The sentences

Ceftriaxone for methicillin-susceptible <i>Staphylococcus aureus</i> bloodstream infections is associated with increased short-term mortality: a systematic review and meta-analysis.